Birmingham, West Midlands -- (SBWIRE) -- 12/10/2013 -- Value Penny Stocks issues special report on Galena Biopharma Inc (NASDAQ:GALE), Quiksilver, Inc. (NYSE:ZQK), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Organovo Holdings Inc (NYSEMKT:ONVO).
Galena Biopharma Inc (NASDAQ:GALE) ended its recent business day with the loss of -3.16% and closed at the price of $4.29 after opening at $4.50. The stock traded during its last trading session with the total volume of 4,818,316 shares, as compared to its average volume of 5.51 million shares. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Has GALE Found The Bottom and Ready To Move Up? Find Out Here
Quiksilver, Inc. (NYSE:ZQK) remained among the day decliners and traded with volume of 4,742,467 shares in the last session, as compared to average volume of 1.50 million shares. In comparison with 52 week range of $3.32 - $9.29, it faced lowest price of $7.85 during the last trading session whereas its day highest price was $8.36. The company’s total market capitalization is $1.35 billion, along with 168.37 million shares outstanding. Quiksilver, Inc. designs, develops, markets, and distributes branded apparel, footwear, accessories, and related products primarily for men, women, and children. It also offers snowboarding equipment. The company provides its products for various activities, including casual and outdoor lifestyle associated with surfing, skateboarding, snowboarding, BMX and motocross, beach and board riding sports, rally car, and other activities.
Has ZQK Found The Bottom And Ready To Gain Momentum? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) showed 4,741,593 shares in volume during the last trading session, while the average trading volume remained 6.05 million shares. The stock kicked off its trading session at $5.91 and closed at $5.82 after declining -2.81%. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
Organovo Holdings Inc (NYSEMKT:ONVO) stock traded during its last trading session with the total traded volume of 4,173,526 shares versus its average volume of 7.93 million shares. The company opened its trade at the price of $9.60 and its closing price was $10.10 after gaining 5.32% for the day. Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company?s 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern.
Why Should Investors Buy ONVO After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)